期刊文献+

左旋肉碱对腹膜透析病人贫血及肌力的影响

Effect of L-carnitine Supplementation on Anemia and Muscle Strength in Peritoneal Dialysis Patients
下载PDF
导出
摘要 目的观察静脉应用左旋肉碱(可益能)对腹膜透析病人血浆肉碱水平、血红蛋白水平及肌力的影响。方法选择有明显疲乏无力、肌肉酸痛症状伴或不伴贫血的慢性腹膜透析患者38例为实验组,同时选取29例无肌肉症状伴或不伴贫血的慢性腹膜透析患者作为对照组,观察两组患者血浆肉碱水平情况,静脉给予可益能15mg/kg,隔日1次,应用24周后,血红蛋白水平及肌力的改善情况。结果实验组血浆游离肉碱(FC)水平明显低于对照组,而酯酰肉碱(AC)与游离肉碱比值则相反;给予可益能静脉注射24周后,实验组血浆总肉碱(TC)、FC、AC较治疗前增加,AC/FC值下降,患者肌肉酸痛症状得到改善,上肢握力增加,贫血者血红蛋白(Hb)水平增高,促红素(rHuEPO)用量减少;静脉应用可益能对腹膜透析患者脂代谢无影响。结论给予可益能静脉应用可以纠正腹膜透析患者肉碱缺乏所引起的相关症状,改善贫血,增加患者肌力,且无明显不良反应。 Objective To study the effect of carnitine supplementation on plasma carnitine fractions,heamoglobin levels and muscle strength in peritoneal dialysis patients.Methods 38 peritoneal dialysis patients with muscular weakness,fatigue,or cramps/aches,and anemia or not were included,also randomly selecting 29 peritoneal dialysis patients who were completely free of muscular symptoms,and anemia or not.Compared with plasma carnitine leves between those two groups,patients with muscular symptoms were given a dose of 15 mg/kg intravenous injection every other day for 24 weeks.Then,assess whether L-carnitine treatment was sufficient to alleviate peritoneal dialysis patients'muscular symptoms and to understand how carnitine affectsed the Hb in anemia patients.Results Plasma free carnitine(FC)of patients who had muscular weakness and fatigue,was lower than those free of muscular symptoms,Acyl carnitine and free carnitine ratio (AC/FC)were opposite.After 24 weeks of L-carnitine supplementation plasma FC,AC,and total carnitine (TC)had increased,conversely,AC/FC ratio were decreased.Almost all petients treated with L-carnitine had improvement in muscular symptoms,muscular power were strengthened.At the end of study,in carnitine patients who had anemia the heamoglobin levels were increased and the dose of recombinant human erythropoietin(rHuEPO) were strongly reduced.After 24 weeks of L-carnitine supplementation,lipid metablism showed no demonstrable changes.Conclusion L-carnitine supplementation can alleviate dialysis-associated muscular symptoms,strengthen muscle strength and increase heamoglobin levels,reduce the rHuEPO requirement,with preventing negative lipid effects.
出处 《河南科技大学学报(医学版)》 2009年第4期258-260,共3页 Journal of Henan University of Science & Technology:Medical Science
关键词 左旋肉碱 腹膜透析 贫血 促红素 握力 L-carnitine peritoneal dialysis anemia rHuEPO handgrip strength
  • 相关文献

参考文献10

  • 1Wanner C, Forstner-wanner S, Rossle C,et al. Carnitine metabolism in patients with chronic renal failure: Effect of L- carnitine[ J]. Kidney Int,1987,32(22) :132 -135. 被引量:1
  • 2强玲,汪涛,胡昭.握力:一种评估腹膜透析患者营养状况的方法[J].中国临床营养杂志,2006,14(3):149-153. 被引量:17
  • 3焦莉莉,周福德,徐国宾,王学晶,董捷,李海霞,夏铁安.血液透析和腹膜透析患者血浆游离和总肉毒碱水平的观察[J].中华检验医学杂志,2007,30(3):264-268. 被引量:8
  • 4杨瑞锋,李志艳,徐国宾,夏铁安.肉毒碱的生物学特性及其与临床疾病的关系[J].中国实验诊断学,2005,9(2):310-313. 被引量:15
  • 5Alhomida A S. Effect of chronic renal hemodialysis on serum total, free and acyl carnitine concentrations in adult chronic pyelonephritis patients[ J]. Arch Med Res, 1997,28 ( 1 ) : 101. 被引量:1
  • 6Dumitru C,David P, Anthony H, et al. Free and esterified carnitine in continuous ambulatory peritoneal dialysis patients [ J ]. Kidney Int, 1996,49 : 158 - 162. 被引量:1
  • 7Wanner C, Forstner-Wanner S, Rossle C, et al, Horl WH. Carnitine metabolism in patients with chronic renal failure: effect of L-carnitine supplementation [ J ]. Kidney Int, 1987,32(supp122) : 132 - 135. 被引量:1
  • 8Yasuhiro S, Yoshihiro M, Toru S, et al. Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients[ J ]. Am J of Kidney Dis, 1998,32:258 - 264. 被引量:1
  • 9Josef K, Gert M, Elisabeth L, et al. Anemia and carnitine supplementation in hemodialyzed patients [ J ]. Kidney Int, 1999,55 ( Supp169 ) ,93 - 106. 被引量:1
  • 10Weschler A, Aviram M, Levin M, et al. High dose of L-carnitine increases platelet aggregation and plasma triglyceride levels in uremic patients on hemodialysis[ J ]. Nephron , 1984,38: 120 - 124. 被引量:1

二级参考文献49

  • 1杨瑞锋,李志艳,徐国宾,夏铁安.肉毒碱的生物学特性及其与临床疾病的关系[J].中国实验诊断学,2005,9(2):310-313. 被引量:15
  • 2Rebouche CJ, Bosch EP, Chenard CA, etal. Utilization of dietary precursors for camitine biosynthesis in human adults[J]. J Nutr, 1989,119(12): 1907. 被引量:1
  • 3Engel AG, Rebouche CJ. C amitine metabolism and inborn errors[J]. J Inherit Metab Dis, 1984,7(suppl 1):38. 被引量:1
  • 4Rebouche CJ, Engel AG. Camitine metabolism and deficiency syndromes[J]. Mayo Clin Proc, 1983,58(8):533. 被引量:1
  • 5Corsi M. Clinical aspects of human carnitine deficiency[M]. New York:Plenum Press, 185. 被引量:1
  • 6Lahjouji K, Mitchell GA, Qureshi IA. Carnitine transport by organic cation transporters and systemic camitine deficiency[J]. Mol Genet Metab,2001,73(4) :287. 被引量:1
  • 7Bieber LL. Camitine[J]. Annu Rev Biochem, 1988,57:261. 被引量:1
  • 8Joaquin Arenas,Juan C Rubio, Miguel A,et al. Biological roles of L-carnitine in perinatal metabolism[J]. Early Hum Der, 1998,53(suppl) :43. 被引量:1
  • 9Jean-Paul Bonnefont, France Demaugre, Carina Prip-Buus, et al. Carnitine Palmitoyltransferase Deficiencies[J]. Mol Gen Metab, 1999,68(4):424. 被引量:1
  • 10Rubio-Gozalbo ME, Bakker JA, Waterham HR, et al. Camitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects[J]. Molecular Aspects of Medicine, 2004,25(5 -6):521. 被引量:1

共引文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部